Myopia is a refractive error (blurred vision at a given distance) that affects about 30% of the world's population. This proportion is increasing so quickly that it ...

Langis Michaud has received research funding from Bausch and Lomb, Neurolens and Fitlens. He has received speaker's fees from Johnson and Johnson and Essilor. Université de Montréal provides ...

There may also be ways to control the growth of myopia. Myopia treatments have been shown to reduce a person’s myopia by up to 60 percent, which could reduce the need for wearing glasses or contact ...

Other factors that can affect progression include how soon myopia is treated and a person’s age. Some people with MMD do not experience vision loss. The timeline of MMD progression varies ...

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...